1. Neuronal Signaling
  2. Amyloid-β
  3. Aducanumab

Aducanumab  (Synonyms: BIIB037)

目录号: HY-P9967 纯度: 99.25%
COA

Aducanumab (BIIB037) 是一种选择性靶向聚集的 β 淀粉样蛋白 () 的人单克隆抗体。Aducanumab 显示出脑渗透性,能够用于阿尔茨海默病 (AD) 研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Aducanumab Chemical Structure

Aducanumab Chemical Structure

CAS No. : 1384260-65-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥2300
In-stock
5 mg ¥5800
In-stock
10 mg ¥9800
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research[1].

体内研究
(In Vivo)

Aducanumab (30 mg/kg,腹腔注射,单剂量) 在 22 个月大的 Tg2576 转基因小鼠中结合所有形态类型的脑 Aβ 斑块,包括弥漫性 Aβ 沉积和致密性 Aβ 斑块[1]
Aducanumab (0.3-30 mg/kg, 腹腔注射, 每周一次, 6 个月) 在 9.5 到 15.5 个月大的 Tg2576 转基因小鼠中以剂量依赖性方式减少可溶性和不溶性 Aβ[1]
Aducanumab (10 mg/kg, 腹腔注射, 每周, 6 个月) 可将 18 个月大的 Tg2576 小鼠的细胞内钙恢复至控制水平[2]
Aducanumab (0.4-1 mg/mL, 脑室注射, 20 分钟) 在 Tg2576 小鼠中可导致淀粉样蛋白负荷快速减少,从而促进斑块清除[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 9.5- to 15.5-month-old Tg2576 transgenic mice [1]
Dosage: 0.3-30 mg/kg
Administration: Intraperitoneal injection (i.p.), weekly, 6 months
Result: Increased recruitment of Iba-1-positive microglia to Aβ plaques.
Animal Model: 18-month-old Tg2576 mice[2]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.), weekly, 6 months
Result: Restored neurite baseline calcium to control levels.
Decreased the number of neurites with elevated levels of calcium after 2 weeks.
Decreased the percentage of cell bodies with calcium overload.
Restored the levels of VILIP and SERCA to control levels.
Increased the cell numbers of NR1 and NR2A.
Animal Model: 22-month-old transgenic Tg2576 mice[2]
Dosage: 0.4-1 mg/mL
Administration: Intracerebroventricular injection (ICV), 20 min
Result: Decreased the number of amyloid plaque.
Decreased the size of the remaining individual plaques.
Reduced amyloid plaque burden.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

阿杜那单抗

运输条件

Shipping with dry ice.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料

纯度: 99.25%

参考文献

Aducanumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Aducanumab
目录号:
HY-P9967
需求量: